Stephen Patek

Stephen Patek is currently the Director of Algorithm Engineering at Dexcom, focusing on Therapeutics, Diagnostics, and Insights. As a co-inventor of the artificial pancreas algorithm embedded in Control-IQ, Stephen has significantly improved the lives of individuals with type 1 diabetes. They co-founded TypeZero Technologies, serving as Vice President of R&D until its acquisition by Dexcom, and hold 15 US patents in various technical areas. Previously, Stephen was a full professor at the University of Virginia's School of Engineering and Applied Science, where they taught hundreds of students and contributed to numerous research publications. Stephen earned a Ph.D. in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology, along with a Master’s Degree in the same field and a Bachelor’s Degree in Electrical Engineering from the University of Tennessee, Knoxville.